Company profile
Aplex Bio company profile
APLEX Bio is a Swedish start-up founded in 2020 developing and commercializing a next-generation hyperplexed molecular detection technology for analysis of massive numbers of biomarkers both in-vitro and in-situ. The technology enables applications from research to mass-scale in-vitro diagnostics (IVD) and precision diagnostics. APLEX Bio is based in Stockholm at the Karolinska Institute (KI) campus and is part of KI Innovations.
Business identity
- Website
- https://www.aplex.bio/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2020-01-01
Headquarters
- Headquarters
- Solna, Stockholm, Sweden
- Postal code
- 171 65
- Country code
- SE
- Continent
- Europe